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Functional brain-imaging techniques used in humans
and animals, such as functional MRI and intrinsic
optical signal (IOS) imaging, are thought to largely
rely on neurovascular coupling and hemodynamic
responses. Here, taking advantage of the well-
described micro-architecture of the mouse olfactory
bulb, we dissected the nature of odor-evoked IOSs.
Using in vivo pharmacology in transgenic mouse
lines reporting activity in different cell types, we
show that parenchymal IOSs are largely indepen-
dent of neurotransmitter release and neurovascular
coupling. Furthermore, our results suggest that
odor-evoked parenchymal IOSs originate from
changes in light scattering of olfactory sensory
neuron axons, mostly due to water movement
following action potential propagation. Our study
sheds light on a direct correlate of neuronal activity,
which may be used for large-scale functional brain
imaging.INTRODUCTION
In the last decades, imaging techniques have allowed us to
watch the brain at work with extraordinary details and have pro-
vided an in-depth understanding of how neural networks func-
tion. In humans, non-invasive imaging techniques do not directly
measure electrical signals but rather measure correlates of
neuronal activity. Functional MRI (fMRI) of blood-oxygen-level-
dependent (BOLD) contrast relies on changes in blood oxygen-
ation in active brain regions (Logothetis and Wandell, 2004;
Logothetis et al., 2001). Intrinsic imaging, either called intrinsic
optical signals (IOSs) imaging, near-infrared spectroscopy
(NIRS), or 2D optical imaging spectroscopy (2D-OIS), is thought
to reflect cerebral blood flow and oxygenation level changes(Grinvald et al., 1999; Martin et al., 2002; Murkin and Arango,
2009), whereas diffusion fMRI measures water diffusion (Le
Bihan et al., 2006). Because all thesemeasurements are indirect,
it is crucial to understand their relation to neuronal activity to
properly interpret functional brain-imaging data.
In animal models, IOSs have been used as a surrogate of
BOLD-fMRI to study neurovascular coupling (Berwick et al.,
2002; Cardoso et al., 2012; Niessing et al., 2005; Schummers
et al., 2008; Sirotin and Das, 2009). Additionally, they have
been extensively used for brain mapping in different species
and several brain regions: visual, somatosensory, auditory, and
gustatory cortices (Accolla et al., 2007; Accolla and Carleton,
2008; Frostig et al., 1990; Grinvald et al., 1986; Harrison et al.,
1998), as well as the olfactory bulb (OB) (Abraham et al., 2004,
2014; Meister and Bonhoeffer, 2001; Rubin and Katz, 1999; Vin-
cis et al., 2012). This technique reports changes in brain-tissue
reflectance induced by neuronal activity (Grinvald et al., 1999).
Such changes depend on incident light absorption by intrinsic
chromophores and incident light scattering by the tissue refrac-
tion index inhomogeneities (Grinvald et al., 1999; Zepeda et al.,
2004). At longer wavelengths (650–850 nm), variations in light
scattering are thought to dominate IOS sources (Cohen et al.,
1968; Frostig et al., 1990; Grinvald et al., 1999). At shorter wave-
lengths (450–650 nm), hemoglobin absorbance dominates, with
variations in absorbance levels between oxy- and deoxyhemo-
globin (Frostig et al., 1990). Both variations in blood flow and
oxygenation can contribute to IOSs. It has therefore been pro-
posed that, at shorter wavelengths (450–650 nm), IOSs originate
from hemodynamics, following astrocyte-mediated neurovascu-
lar coupling (Gurden et al., 2006; Schummers et al., 2008).
In the present study, we unexpectedly found that stimulus-
evoked parenchymal IOSs in the OB are independent of neuro-
vascular coupling. We present evidence that parenchymal
IOSs in the OBmainly come from the activity of olfactory sensory
neuron (OSN) axons and are independent of neurotransmitter
release. Our findings represent a significant step forward in un-
derstanding the origin of IOSs and provide crucial information
about the different physiological correlates of neuronal activityCell Reports 12, 313–325, July 14, 2015 ª2015 The Authors 313
that can be monitored by large-scale non-invasive functional
imaging techniques.
RESULTS
Parenchymal IOSsAre Independent of Hemodynamics in
the OB
To study the origin of in vivo stimulus-evoked intrinsic signals,
we first assessed whether odor-evoked IOSs were dependent
on hemodynamic changes in awake head-restrained mice
(Gschwend et al., 2012; Vincis et al., 2012). We recorded IOSs
elicited by different odorant stimuli, varied the wavelength of
the incident light, and quantified the amplitude and kinetics of
activated regions of interest over time (Figures 1A–1I). At all
wavelengths, we found discrete circular-shaped activated areas
corresponding to OB glomeruli (Abraham et al., 2004; Bathellier
et al., 2007, 2008; Belluscio et al., 2002; Meister and Bonhoeffer,
2001; Rubin and Katz, 1999; Uchida et al., 2000; Vincis et al.,
2012) (Figures 1A and 1B). The amplitude of glomerular IOSs
increased at shorter wavelengths, always staying negative
(Figures 1C and 1F). In contrast, stimulus-evoked IOSs in blood
vessels were barely detectable at longer wavelength and varied
in sign at shorter wavelength (Figures 1D and 1F). Indeed, at
605 nm, some blood vessels showed an increase in reflectance
(whitening in Figure 1A) whereas others showed a decrease in
reflectance (darkening in Figure 1A). We split these two popula-
tions for further quantifications (Figure 1F). Almost all blood
vessels displayed a decrease in reflectance at 546 nm. The
blood vessels exhibiting negative IOSs at 605 nm had the largest
(negative) IOSs at 546 nm. The shapes of the IOSs from glomeruli
and blood vessels were strikingly different. Glomerular re-
sponses started shortly after stimulus onset and grew continu-
ously until stimulus offset. In contrast, blood vessel responses
were delayed and reached a peak before the stimulus offset
(Figures 1G and 1I). Additionally, we observed a tendency for
positive IOSs in blood vessels to arrive later than negative signals
(Figures 1E, 1I, and S1). In order to avoid a potential bias
originating from the manual selection of regions of interest, we
also analyzed our data using independent component analysis
(ICA). This unbiased approach led to the same results, sepa-
rating blood vessels in two categories according to the sign of
their response at 605 nm and revealing a delayed latency from
stimulus onset in blood vessels relative to glomeruli (Figures
1J–1L). Altogether, these observations show that, in awake
mice, the kinetics of glomerular IOSs is significantly different
from the ones arising from blood vessels.
In order to further pharmacologically dissect out the origin of
IOSs in the OB, we planned to carry out experiments in anesthe-
tized mice. Knowing that a number of anesthetics affect neuro-
vascular coupling (Masamoto and Kanno, 2012; Nakao et al.,
2001), we first checked that our conclusions from recordings in
awake mice still held under anesthesia. The main effect of our
anesthetics was to slow down the kinetics of vascular IOSs
without affecting the kinetics of glomerular IOSs (Figures 2A–
2E; amplitude awake = 1.95& ± 0.14&, 2.69& ± 0.24&, and
8.76& ± 1.01& at 700, 605, and 546 nm, respectively; amplitude
anesthetized = 2.27& ± 0.3&, 3.75& ± 0.79&, and 6.28& ±
1.32& at 700, 605, and 546 nm, respectively; two-way314 Cell Reports 12, 313–325, July 14, 2015 ª2015 The Authorsrepeated-measures ANOVA; F(1,9) = 0.17; p = 0.69; 20%–80%
rise time awake versus anesthetized; two-way repeated-mea-
sures ANOVA; F(1,9) = 0.41; p = 0.54). Additionally, no significant
increase in reflectance (i.e., whitening [i.e., positive IOSs]) was
observed in blood vessels. Most importantly, our previous
finding on latency discrepancy between vascular and glomerular
IOSs still held (Figures 2B–2D). Indeed, glomerular odor-evoked
IOSs had always shorter latency from stimulus onset (455 ±
31 ms at 546 nm and 278 ± 42 ms at 605 nm) than blood vessels
IOSs (1,384 ± 108 ms at 546 nm and 1,077 ± 136 ms at 605 nm).
These results were obtained when analyzing the time course of
the local component of intrinsic signal, which is extracted by
filtering out specific spatial frequencies from the raw data. How-
ever, similar results were found on the raw (unfiltered) and diffuse
component of IOSs (Figure S2), therefore ruling out a potential
bias introduced by the spatial filter.
A direct measurement of blood flow changes (by injection of
fluorescein dextran in the bloodstream) gave us the same latency
values, with hemodynamics lagging odor onset by more than 1 s
(Figures 2F and 2G). This delay matched the values of vascular
IOSs (Figure 2H). In our recording conditions, vascular IOSs
are thus likely to reflect mostly changes in blood flow. With
different recording techniques (fluorescence and IOS), different
analyses (ROI-based and ICA), and different levels of arousal
(awake and under anesthesia), glomerular IOSs consistently
preceded blood vessel response by about 1 s (Figure 2H). This
latency discrepancy led us to conclude that changes in blood
flow do not contribute to the initial rise of intrinsic signals we
recorded in activated glomeruli.
However, one has to note that the delay in vascular IOSs does
not necessarily mean that vascular changes do not contribute
at all to glomerular IOSs. Indeed, it is possible that a late compo-
nent of glomerular IOSs stems from hemodynamics. Given the
difference in wavelength dependency between IOSs originating
from light scattering and from hemodynamics (Frostig et al.,
1990), we compared the slope of the initial glomerular response
to the slope of that response between 3 and 4 s after the odor
onset (Figure 2B). This ratio was constant at the three wave-
lengths recorded (Figure 2E), therefore ruling out the contribution
of a source of different origin than that of the initial response.
Oxyhemoglobin (HbO) (i.e., hemoglobin carrying oxygen mol-
ecules) has a different absorption spectrum than deoxyhemo-
globin (Hb) (Figure 2I). It is thus possible that changes in the
ratio of HbO to Hb contribute to changes in IOSs. In the first
second of IOSs, the total amount of hemoglobin (HbT) being
constant (see previous paragraphs), changes in HbO and Hb
concentrations should be equal and opposite. As a conse-
quence, signals recorded at isosbestic points (i.e., when Hb
and HbO absorbances are equal) should be flat. Likewise,
signals should be maximal when the difference in absorbance
is the largest. In our recordings, we found the highest ampli-
tude at 546 nm, close to an isosbestic point, and comparable
amplitudes at 700 and 810 nm (Figures 2J–2L), two wave-
lengths at which the differences in absorbance are very different
(Figure 2I).
As a conclusion, neither blood flow nor blood oxygenation
changes can explain the first second of the glomerular intrinsic
signals. Given the wavelength invariance of the response
Figure 1. Odor-Evoked Glomerular and
Vascular Intrinsic Optical Signals Have
Different Kinetics in Awake Mice
(A) Blood vessel pattern of the dorsal OB (Morph)
and IOS glomerular map evoked by ethyl butyrate
(5% in air) recorded at three different wavelengths
in the same animal (gray look-up table [LUT]:
0.005 to 0.005 DR/R). Green and cyan/magenta
dotted lines and arrowheads indicate regions of
interest (ROIs) placed over an activated glomer-
ulus and blood vessels, respectively.
(B) Rightmost image shown in (A) (546 nm) after
adjusting the look-up table (0.02 to 0.02 DR/R).
(C) IOS time course of the glomerulusmarked in (A)
and (B) (green ROI and arrow) at the different
wavelengths.
(D) IOS time course of the blood vessels marked in
(A) and (B) (magenta and cyan ROIs and arrow-
heads) at the different wavelengths. Note the
positive IOSs in the blood vessel marked in
magenta at 605 nm.
(E) IOS traces shown in (C) and (D) but scaled for
comparison. The magenta dotted line has been
flipped for better comparison. Note the delay from
odor onset of the blood vessel response (white
and magenta arrowheads) compared to glomer-
ular ones (black arrowhead).
(F) Averageamplitude of IOSs recorded in glomeruli
(green) and in blood vessels (magenta and cyan).
Note the difference in amplitude between the two
groups of blood vessels, particularly at 605 nm.
(G) Average rise time measured between 20% and
80%of the response amplitude in glomeruli (green)
and inblood vessels (magenta andcyan). Two-way
ANOVA with repeated-measures F(2, 12) = 7.67;
p = 0.007 for the ROI effect with Tukey’s correction
for post hoc multiple comparison analysis.
(H) Time of the peak of the IOS responses in
glomeruli (green) and in blood vessels (magenta
and cyan) relative to odor onset. The dashed
line at 5 s represents the end of the odor appli-
cation. Two-way ANOVA with repeated-measures
F(2, 12) = 10.6; p = 0.002 for the ROI effect with
Tukey’s correction for post hoc multiple compar-
ison analysis.
(I) Latency from odor onset of the IOS responses
in glomeruli (green) and in blood vessels (magenta
and cyan). Two-way ANOVA without repeated-
measures F(2, 33) = 13.2; p < 104 for the ROI
effect with Tukey’s correction for post hoc multi-
ple comparison analysis.
(J) Independent component analysis on the raw DR/R time series extract glomerular signal (ICA no. 6), positive signals in blood vessels (ICA no. 8), and negative
signals in blood vessels (ICA no. 7) at 605 nm. The same recording presented in (A)–(E) was used here. The temporal profiles extracted by the ICA are presented
at the bottom whereas Z score maps are presented above. Note that the antero-medial and the postero-lateral clusters of glomeruli are often separated by the
ICA (compare A and J).
(K) Latency from odor onset of the IOS responses in glomeruli (green) and in blood vessels (magenta and cyan) calculated from the ICA waveforms. Two-way
ANOVA without repeated-measures F(2, 30) = 92.6; p < 104 for the ROI effect with Tukey’s correction for post hoc multiple comparison analysis.
(L) ICA waveforms shown in (J) scaled for comparison. The magenta dotted line has been flipped for better comparison. Note the delay from odor onset of the
blood vessel response (cyan and especially magenta) compared to glomerular ones.
The scale bars represent 400 mm in (A) and (J). The light gray boxes represent odor application. * indicates corrected post hoc test p < 0.05. For clarity, significant
comparisons are only indicated between wavelength (in F) or between ROI types (in G–K). Data are presented as mean ± SEM. See also Figure S1.waveform, we conclude that vascular and parenchymal IOSs
have different origins and need to be treated separately. In the
OB, parenchymal IOSs do not result from hemodynamic features
such as blood volume and oxygenation and thus must originatefrom variations in light scattering. In order to investigate which
cellular components of the OB network give rise to light scat-
tering changes, we pharmacologically dissected out the origin
of in vivo stimulus-evoked IOSs.Cell Reports 12, 313–325, July 14, 2015 ª2015 The Authors 315
Figure 2. Parenchymal Intrinsic Optical Sig-
nals of Glomerular-Evoked Activity Do Not
Depend on Hemodynamics
(A) Blood vessel pattern of the dorsal OB (Morph)
and IOS glomerular map evoked by methyl ben-
zoate (5% in air) recorded at three different
wavelengths in the same anesthetized animal
(gray LUT: 0.0035 to 0.0015 DR/R for 700 and
605 nm and 0.01 to 0.006 DR/R for 546 nm).
Green and magenta dotted lines indicate ROIs
placed over an activated glomerulus and blood
vessel, respectively.
(B) IOS time course of the glomerulus and the
blood vessel marked in (A) (green and magenta
ROIs and arrow, respectively) at the different
wavelengths.
(C) IOS traces shown in (B) normalized for
comparison. Note the delay from odor onset of
the blood vessel traces (magenta) compared to
glomerular ones (green).
(D) Average response latencies computed for
glomeruli (green) and blood vessels (magenta;
Mann-Whitney U test; glomeruli versus blood
vessels; n = 5 mice except for blood vessels at
605 nm, n = 4 mice; U(8) = 2.5, p = 0.008 and
U(7) = 0, p = 0.016 at 546 and 605 nm, respec-
tively). n.d., not determined.
(E) Average slope ratios of the glomerular re-
sponses measured at different wavelengths
(3rd second over 1st second response period;
see B). One point represents one animal and is
an average of many glomeruli (Friedman test;
p = 0.52; F = 1.6).
(F) (Left) resting fluorescence on the dorsal OB after fluorescein dextran injection in the tail vein. (Right) Average map of blood flow change evoked by ethyl
butyrate is shown. The black outlined areas point out examples of odor-evoked activated ROIs.
(G) Temporal profiles of the two ROIs marked in (F).
(H) Comparison of IOSs and hemodynamic response latencies obtained in different conditions and with different techniques. The columns labeled ROI corre-
spond to manually selected ROIs in anesthetized animals (gray bars; data from Figure 2D) and in awake mice (color-filled bars; data from Figure 1I). The columns
labeled ICA correspond to the ICA analysis on data from anesthetized mice (gray bars) and in awake mice (color-filled bars; data from Figure 1K). The middle bar
(fluo) corresponds to the data collected in anesthetized mice after a tail vein injection of fluorescein-dextran. There are no statistically significant differences
between the latencies of IOSs measured in blood vessel in the five conditions (Kruskal-Wallis; K(5,27) = 3.28; p = 0.51). All glomeruli latencies are significantly
smaller than any latency from blood vessels. ANOVA with Fisher LSD post hoc test F(1,36) = 178; p < 104.
(I) Absorption spectra of oxyhemoglobin (HbO) and deoxyhemoglobin (Hb) (data from Takatani and Graham, 1979), plotted on a logarithmic axis. Black dotted line
highlights wavelength at which IOS recording is performed.
(J) IOS glomerular maps evoked by methyl benzoate (3.33% in air) recorded at two different wavelengths (810 and 700 nm; LUT: 0.0035 to 0.0015 DR/R).
(K) Time course of the activation of the glomerulus marked in (J), imaged at 700 nm and 810 nm.
(L) Average amplitude across mice of IOSs recorded at 700 nm (black) and 810 nm (WL, wavelength; red; paired t test; n = 3; t(2) = 3.03; p = 0.094).
The scale bars represent 100 mm in (A) and (I) and 200 mm in (F). Data are presented as mean ± SEM. See also Figure S2.Parenchymal IOSs in the OBOriginate fromOSN Activity
OSNs’ axonal projections coalesce in the OB glomeruli, where
they formaxo-dendritic glutamatergic synapseswith thedendritic
tufts of both output neurons (mitral and tufted [M/T] cells) and a
heterogeneous population of interneurons called periglomerular
(PG) cells (Berkowicz et al., 1994; Ennis et al., 1996) (Figure 3A).
Glutamate released from OSNs activates post-synaptic iono-
tropic AMPA and NMDA receptors located on M/T and PG cells
(Aroniadou-Anderjaska et al., 1997; Ennis et al., 1996). The activa-
tion of PG cells, in turn, triggers the release of dopamine and
GABA, which inhibits OSNs via presynaptic metabotropic D2
and GABAB receptors (Ennis et al., 1996; Hsia et al., 1999;
McGann et al., 2005; Petzold et al., 2008). All synaptic contacts
between these cell types lie within 200 mm of OB’s surface, thus
rendering them accessible to in vivo pharmacological manipula-316 Cell Reports 12, 313–325, July 14, 2015 ª2015 The Authorstion. In order to monitor the activity of the cellular partners of the
OB circuitry, we used mouse lines expressing the Ca2+-sensitive
fluorescent protein GCaMP3 in PCDH21-expressing cells (i.e.,
M/T cells), in OMP-expressing cells (i.e., OSNs), and in GFAP-ex-
pressing cells (i.e., astrocytes). We additionally used amouse line
reporting synaptic vesicle fusion in OSNs (OMP-synaptopHluorin
[OMP-SpH]; Bozza et al., 2004). These mouse lines, reporting
activity from different synaptic partners, allowed us to carefully
control for the specificity of drug effects on odor-evoked IOSs.
We firstmade surewe could blockOSN toM/T cell glutamater-
gic synaptic transmission in vivo with AMPA and NMDA receptor
antagonists (FiguresS3A–S3E). Second,we verified inOMP-SpH
mice that pharmacological modulation of GABAB (Figures S3F–
S3J) and D2 (Figures S3K–S3O) receptors altered release from
OSN terminals. After validationof our pharmacological approach,
Figure 3. Parenchymal IOSs Are Independent of Post-synaptic Activity and Neurovascular Coupling
(A) (Left panel) Schematic representation of OB glomerular circuitry. Right images show average maps of odor-evoked activity reported by IOSs in control
condition (ACSF) and after topical application of a first drug mix (Cockt. 1) containing APV (1 mM), NBQX (0.1 mM), CGP (1 mM), and sulpiride (1 mM) and of a
second drugmix (Cockt. 2) containing Cockt.1 with addition of mGluRs antagonist MCPG (100 mM), CPPG (10 mM), and LY 341495 (2 mM). The reflectance of IOSs
is represented as DR/R (see Experimental Procedures). LUT: 0.01 to 0.006 DR/R. Black arrows point to an example of odor-evoked activated glomeruli. The
scale bar represents 100 mm.
(B) (Left panel) Traces showing the time course of odor-evoked activity from the glomerulus marked in (A) for three conditions (ACSF, black; Cockt.1, blue; and
Cockt.2, red; mean ± SEM of eight trials for each condition). Light gray vertical bar represents odor stimulation. (Central panel) Average values of glomeruli
amplitude response after Cockt.1 (blue circles) and Cockt.2 (red circles) application are shown, plotted against amplitude values in control condition (ACSF;
Wilcoxon signed-rank test; Cockt.1 versus Cockt.2; p = 0.09; n = 149 glomeruli from fourmice). (Right panel) Average values of glomeruli amplitude response after
application of Cockt.1 (blue) and Cockt.2 (red) across mice are shown. Values are normalized relative to control condition (ACSF; paired t test t(3) = 0.032;
p = 0.98; n = 4 bulbs from four mice).
(C) Same drug conditions as in (A). (Left panel) The location of the fluorescent reporter is represented in green. (Right images) Averagemap of odor-evoked activity
reported by OMP-SpH is shown. White arrows point to an example of odor-evoked activated glomeruli. The fluorescence is represented as DF/F (see Experi-
mental Procedures). LUT: 0.015 to 0.05 DF/F. The scale bar represents 100 mm.
(D) Same as in (B). (Left panel) Traces show the time course of odor-evoked activity from the glomerulus marked in (C) for three conditions (mean ± SEM of eight
trials for each condition). (Central panel) Wilcoxon signed-rank test is shown; Cockt.1 versus Cockt.2; p = 1e12; n = 125 glomeruli from four mice. (Right panel)
Paired t test is shown; t(3) = 1.1; p = 0.35; n = 4 bulbs from four mice.
(E) Same drug conditions as in (A). (Left panel) The location of the fluorescent reporter is represented in green. (Right images) Averagemap of odor-evoked activity
reported by OMP-GCaMP3 is shown. White arrows point to an example of odor-evoked activated glomeruli. The fluorescence is represented as DF/F (see
Experimental Procedures). LUT: 0.015 to 0.055 DF/F. The scale bar represents 100 mm.
(F) Same as in (B). (Left panel) Traces show the time course of odor-evoked activity from the glomerulus marked in (E) for three conditions (mean ± SEM of eight
trials for each condition). (Central panel) Wilcoxon signed-rank test is shown; Cockt.1 versus Cockt.2; p = 4.0e1; n = 172 glomeruli from four mice. (Right panel)
Paired t test is shown; t(3) = 0.033; p = 0.76; n = 4 bulbs from four mice.
(G) Same drug conditions as in (A). (Left panel) The location of the fluorescent reporter is represented in green. (Right images) Averagemap of odor-evoked activity
reported by GFAP-GCaMP3 is shown. White arrows point to an example of odor-evoked activated glomeruli. The fluorescence is represented as DF/F (see
Experimental Procedures). LUT: 0.0005 to 0.007 DF/F. The scale bar represents 100 mm.
(H) Same as in (B). (Left panel) Traces show the time course of odor-evoked activity from the glomerulus marked in (G) for three conditions (mean ± SEM of eight
trials for each condition). (Central panel) Wilcoxon signed-rank test is shown; Cockt.1 versus Cockt.2; p = 1.6e17; n = 98 glomeruli from four mice. (Right panel)
Paired t test is shown; t(3) = 7.0; p = 0.0059; n = 4 bulbs from four mice.
Data are presented as mean ± SEM. See also Figures S3–S5.
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we tested whether IOSs originated from post-synaptic neurons.
The application of APV, NBQX, sulpiride, and CGP35348
(NMDA, AMPA, D2, and GABAB receptor antagonists, respec-
tively; hereinafter referred to as Cockt.1) did not decrease but
rather increased IOS amplitude (Figures 3A and 3B). Similar re-
sults were obtained on different IOS components at different
wavelengths (Figure S4). An increase in signal amplitude was
similarly observed in OMP-SpH and OMP-GCaMP3 mice, which
most likely reflects the removal of endogenous presynaptic inhi-
bition of OSNsby PGcells throughD2 andGABAB receptors (Fig-
ures 3A–3F). Our data thus suggest that IOSs do not depend on
post-synaptic neuronal activity.
Astrocytes are a key element of neurovascular coupling and
have previously been reported to generate IOSs in the OB (Gur-
den et al., 2006). They can sense glutamate release through
metabotropic receptors (mGluRs). We found that applying
MCPG, CPPG, and LY mGluR antagonists (group I and II, group
III, and group II receptor antagonists, respectively; the cocktail
hereinafter referred to as Cockt.2 contains GluRs, mGluRs,
D2R, and GABABR antagonists) did indeed decrease astrocyte
Ca2+ signals (Figures 3G and 3H). In contrast, blocking mGluRs
hadnoeffect on IOSs,OSNglutamate release, andOSNCa2+ sig-
nals (Figures 3A–3F). Astrocytes also sense glutamate release
through excitatory amino acid transporters (EAAT) (Attwell et al.,
2010; Bernardinelli and Chatton, 2008; Danbolt, 2001). The use
of the general EAAT blocker DL-TBOA alone proved to be unsuit-
able forour experimentsgiven its effectonglutamate release from
OSNs (Figures 4A–4D). Indeed, application of 5 mM DL-TBOA
almost completely abolished vesicle fusion in OSNs in OMP-
SpH mice. Moreover, this effect was reverted by the addition of
ionotropic glutamate receptors (NBQX and APV; Figures 4A–
4D). Application of dihydrokainic acid (DHK), an astrocyte-spe-
cific EAAT blocker, also had no effect on IOSs (Figures 4E–4H).
ATP released by OSNs (Thyssen et al., 2010) can be sensed,
along with its metabolites (ADP and adenosine) by astrocytes
(Doengi et al., 2008). The application of CGS and suramin (broad
P1 and P2 receptor antagonists, respectively) did not affect IOSs
(Figures 4I–4P). Astrocytes are also sensitive to extracellular K+
concentration. They play an important role in K+ siphoning via
inward-rectifier K+ (Kir) channels, which is key in preventing
epileptic activity (Attwell et al., 2010). Application of 1 mM Ba2+,
a broad antagonist of Kir channels, did not affect IOSs (Figures
4Q–4T). The same results were observed when analyzing the
raw images and the diffuse component of IOSs (Figure S5). Like-
wise, DHK, suramin, CGS, Ba2+, and the mGluR antagonists had
very little effect on the resting fluorescence (Figure S5).
Altogether, these results allow us to rule out the contribution of
post-synaptic neurons and astrocytes to parenchymal IOSs
measured in the OB. We can thus conclude that parenchymal
IOSs in the OB do not reflect post-synaptic neuron activity nor
do they reflect neurovascular coupling through astrocytic activ-
ity. Odor-evoked intrinsic signals in the OB rather reflect the ac-
tivity of OSNs.
Parenchymal IOSs Are Independent of Neurotransmitter
Release from OSNs
In order to further confirm that IOS origin is presynaptic, we used
two approaches to block vesicular release from OSNs. Indeed,318 Cell Reports 12, 313–325, July 14, 2015 ª2015 The AuthorsOSNs might release some unknown and/or unconventional
transmitter (e.g., neuropeptides) along with glutamate. The re-
ceptor of such transmitter would have been missed in our
initial pharmacological dissection. We first measured SpH and
IOS odor-evoked activity in the same OMP-SpH animals before
and after blocking voltage-gated Ca2+ (Cav) channels with 2 mM
Cd2+. The application of this broad Cav antagonist reduced
significantly vesicle fusion but had a minimal effect on intrinsic
signals (Figures 5A–5C). These results suggest that neurotrans-
mitter release and vesicle fusion are not major contributors to
IOSs. In order to further ascertain that conclusion, we used a
conditional null mouse lacking the voltage-gated Na+ channel
Nav1.7 in OMP-expressing cells (i.e., OSNs; see Experimental
Procedures; mice referred to as cNav1.7
/; Weiss et al.,
2011). This Na+ channel subunit has been found to be the only
one expressed in glomeruli and OSN axon terminals (Weiss
et al., 2011). Its removal renders mice fully anosmic while preser-
ving OSNs function, including action potential generation (Weiss
et al., 2011). In this mouse line, the average amplitude of the sig-
nals was smaller than in heterozygous controls, but we could still
record odor-specific intrinsic signals (Figures 5D–5G).
Altogether, these data suggest that odor-evoked parenchymal
IOSs in the OB do not depend on the release of neurotransmitter
or other messenger molecule by vesicle fusion from OSNs.
Parenchymal IOSs are thus purely presynaptic and reflect
changes in light-scattering properties of OSN axons in the OB.
Altering Water Diffusion Disrupts IOSs without
Impairing OSN Activity
What could be the nature of changes in OSN axons leading to
intrinsic signals? Activity-induced axonal swelling has been
described in vitro (Fields and Ni, 2010; Tasaki and Byrne,
1983, 1988) and gives rise to measureable optical signals
in vitro (Cohen et al., 1968; Tasaki et al., 1968). These optical
changes reflect water and ion movements across the axonal
membrane (Cohen, 1973). We hypothesized that in vivo func-
tional IOSs are likewise caused by activity-induced cell swelling.
An edema is a pathological disruption of the extracellular
medium that results from altered diffusion of water and solutes.
We used a standard model for general brain edema-water intox-
ication (i.e., systemic injection of distilled water; Manley et al.,
2000) to assess the influence of osmolarity changes in the extra-
cellular space on IOSs. We controlled for the effect of alterations
in overall volume changes by injecting an isotonic solution (NaCl
0.9%; 310 mosm/l). We made sure that water intoxication had
no effect on vesicle fusion in OSNs (Figures 6A–6D). Water
intoxication can be lethal (Manley et al., 2000); we therefore
controlled for vital parameters throughout our experiments
and kept only data where the breathing and heartbeat of the an-
imals were stable or slightly increasing (Figures 6E and 6F). In
agreement with our hypothesis, we found that water intoxication
disrupted IOSs (Figures 6G–6L). IOSs, as opposed to neuro-
transmitter release, are sensitive to the osmolarity of the extra-
cellular space.
In conclusion, odor-evoked parenchymal IOSs are most
likely generated by morphological changes caused by activity-
induced solute and water movements across the membrane of
OSN axons in the OB.
Figure 4. Parenchymal IOSs DoNot Depend
on Astrocytic Activity
(A) Average map of odor-evoked glomerular ac-
tivity measured by fluorescence in OMP-SpHmice
(top row) and IOSs in WT mice (bottom row) in
control conditions (ACSF) in the presence of 5 mM
TBOA and in the presence of TBOA, NBQX, and
APV (5 mM, 0.1 mM, and 1 mM, respectively).
LUT: 0.01 to 0.03 DF/F and 0.02 to 0.03 DR/R
for the fluorescence and IOSs, respectively.
(B) Time course of odor-evoked activity from the
glomeruli marked in (A) for three pharmacological
conditions (mean ± SEM of eight trials).
(C) Individual glomerular response amplitude during
drug applications plotted against amplitude values
in ACSF condition in fluorescence (top; Wilcoxon
signed-rank test; n = 114 glomeruli from threemice,
Z(114) =9.7, p = 1.9e20 and Z(114) =0.94, p =
0.35 forACSFversusTBOAandACSFversus+APV,
NBQX, respectively) and in IOSs (bottom;Wilcoxon
signed-rank test; n = 109 glomeruli from three
mice; Z(109) = 9.1; p = 1.3e19 and Z(109) =
0.016, p = 0.99 for ACSF versus TBOA and
ACSF versus +APV, NBQX, respectively).
(D) Average amplitude acrossmice in fluorescence
(top; paired t test; n=3mice; TBOAversus+NBQX,
APV; t(2) = 6.1; p = 0.025) and in IOSs.
(E) Average map of odor-evoked IOSs in control
condition (Cockt.2) and in presence of DHK
(1 mM). LUT: 0.002 to 0.003 DR/R.
(F) Time courses of odor-evoked activity from the
glomerulus marked in (E) (mean ± SEM of eight
trials).
(G) Individual glomerular IOS amplitude in pres-
ence of DHK plotted against amplitude values in
Cockt.2 condition (Wilcoxon signed-rank test;
n = 64 glomeruli from three mice; Z(64) = 0.12;
p = 0.90).
(H) Average IOS amplitude across mice (n = 3
bulbs from three mice; 108% ± 9% of Cockt.2).
(I) Average map of odor-evoked IOSs in control
condition (Cockt.2) and in presence of CGS
(0.5 mM). LUT: 0.002 to 0.003 DR/R.
(J) Time courses of odor-evoked activity from the
glomerulus marked in (I) (mean ± SEM of eight
trials).
(K) Individual glomerular IOS amplitude in presence of CGS plotted against amplitude values in Cockt.2 condition (Wilcoxon signed-rank test; n = 97 glomeruli
from three mice; Z(97) = 1.5; p = 0.14).
(L) Average amplitude across mice expressed as % of control condition (n = 3 bulbs from three mice; 100.7% ± 2% of Cockt.2).
(M) Average map of odor-evoked IOSs in control condition (Cockt.2; left image) and in presence of suramin (2 mM; right). LUT: 0.002 to 0.003 DR/R.
(N) Time courses of odor-evoked activity from the glomerulus marked in (M) (mean ± SEM of eight trials).
(O) Individual glomerular IOS amplitude in presence of suramin plotted against amplitude values in Cockt.2 condition (Wilcoxon signed-rank test; n = 114
glomeruli from three mice; Z(114) = 1.9; p = 0.059).
(P) Average IOS amplitude across mice (n = 3 bulbs from three mice; 97% ± 2% of Cockt.2).
(Q) Average map of odor-evoked IOSs in control condition (Cockt.2; left) and in presence of Ba2+ (1 mM; right). LUT: 0.002 to 0.003 DR/R.
(R) Time courses of odor-evoked activity from the glomerulus marked in (Q) (mean ± SEM of eight trials).
(S) Individual glomerular IOS amplitude in presence of Ba2+ plotted against amplitude values in Cockt.2 condition (Wilcoxon signed-rank test; n = 111 glomeruli
from three mice; Z(111) = 0.50; p = 0.62).
(T) Average IOS amplitude across mice (n = 3 bulbs from three mice; 105% ± 6% of Cockt.2). Light gray box in (B), (F), (J), (N), and (R) represents odor
presentation.
The scale bars represent 250 mm. See also Figure S5.DISCUSSION
Our study assesses the nature of in vivo IOSs in the mouse OB.
With a wide and complementary set of approaches, we showthat odor-evoked IOSs recorded in glomeruli are unrelated to
hemodynamics (Figures 1 and 2) and are independent of neuro-
vascular coupling (Figures 3 and 4). Parenchymal IOSs are inde-
pendent of neurotransmitter release and vesicle fusion (Figure 5)Cell Reports 12, 313–325, July 14, 2015 ª2015 The Authors 319
Figure 5. Parenchymal IOSs Are Indepen-
dentofNeurotransmitterRelease fromOSNs
(A) Average fluorescence (top) and IOS (bottom)
olfactorymaps evoked by ethyl butyrate (5% in air)
in the same OMP-SpH animal. Images are re-
corded in ACSF (left) and in presence of Cd2+
(2 mM; right). LUT: SpH, 0.01 to 0.03 DF/F and
IOS, 0.0045 to 0.0025 DR/R.
(B) Time courses of SpH (top) and IOS (bottom)
odor-evoked activity from the glomerulus marked
in (A), in control condition (ACSF; black) and inCd2+
(red). The area around the curve represents±SEM.
(C) (Top) Average SpH (green) and IOS (black)
amplitude across mice in presence of Cd2+ (n = 3
bulbs from three mice; paired t test; t(2) = 5.3;
p = 0.034). (Bottom) Individual glomeruli IOS
activity (ordinate) as a function of their SpH activity
(abscissa) in presence of Cd2+ (n = 91 glomeruli
from three mice; Wilcoxon sign rank test;
Z(91) = 6.5; p = 7e11).
(D and E) IOS olfactory map evoked by carvone-
(left) and ethyl butyrate (right; 20% and 2% in air,
respectively) in a cNav1.7
/ (D) and a cNav1.7
+/
mouse (E). LUT: 0.0009 to 0.0003 (D; left image),
0.002 to 0.001 (E; right image) and 0.004 to
0.002 (D; left image), 0.006 to 0.002 (E; right
image) DR/R.
(F) Normalized traces of the activity of the glomeruli marked in (A) and (B) in a cNav1.7
/mouse (top) and cNav1.7
+/mouse (bottom) evoked by ethyl butyrate
(EB) (red) and carvone- (C-) (black).
(G) Averaged odor-evoked IOS amplitudes recorded in cNav1.7
/ (magenta) and cNav1.7
+/ mice (green; n = 6 and 7 bulbs from four and five mice for
cNav1.7
+/ and cNav1.7
+/+, respectively).
The scale bars represent 200 mm in (A) and 250 mm in (D) and (E). Data are presented as mean ± SEM.and depend on solute and water movements in OSN axons (Fig-
ure 6), which deliver peripheral olfactory inputs to the brain.
Thus, parenchymal IOSs represent a different physiological
correlate of neuronal activity than previously thought.
Importance of the Brain Architecture for
Light-Scattering Measurements
Intrinsic optical imaging has been used in the rodent olfactory
system formore than a decade and has been shown to give func-
tionally relevant ‘‘glomerular odor maps’’ (Belluscio et al., 2002;
Rubin and Katz, 1999; Vincis et al., 2012). Indeed, glomeruli
are the entry point of olfactory sensory information to the brain.
They are morphologically and functionally well-defined struc-
tures where axons of OSNs expressing the same odorant re-
ceptor coalesce and form synapses on different OB neurons.
Glomeruli are close to the pia, rendering them optically and phar-
macologically accessible.
Our pharmacological approach aimed at exhaustively block-
ing channels, receptors, and transporters sensing OSN activity.
None of the pharmacological manipulations significantly altered
IOSs without affecting OSN activity (Figures 3, 4, and S3–S5).
Another approach we took consisted in altering transmitter
release from OSNs rather than blocking potential targets (Fig-
ure 5). The results of these experiments are consistent with a pre-
synaptic origin of odor-evoked parenchymal IOSs. The addition
of Cd2+ did indeed reduce vesicle fusion with little effect on IOSs.
Likewise, we couldmeasure odor-evoked signals inmice lacking
Nav channels in OSN terminals. Though we cannot completely
rule out a small contribution of other cell types, like astrocytes320 Cell Reports 12, 313–325, July 14, 2015 ª2015 The Authorsand bulbar neurons, our data suggest that most of odor-evoked
parenchymal intrinsic signals we recorded arise from OSN
axons.
One explanation for the predominant contribution of OSN
axons to parenchymal IOSs is their massive convergence. It is
estimated that 11,000 OSNs project in a given glomerulus in
rodents (Shepherd et al., 2004). Moreover, OSNs that send their
axons to a given glomerulus express the same odorant receptor
(Ressler et al., 1994; Vassar et al., 1994), and their activity tends
to be timed to the breathing cycle (Verhagen et al., 2007). They
are thus conveying the same information synchronously in a
spatially restricted location (Bozza et al., 2004; 100 mm for
the mouse OB glomerulus). In addition, the glomerular layer of
the OB appears to be the brain region with the lowest extracel-
lular space fraction (Zhang and Verkman, 2010) and conse-
quently the highest density of neuropil. These features concur
to maximize the contribution of OSN axons to IOS imaging
in vivo. It is likely that the relative contribution of cellular elements
to parenchymal IOSs may vary between brain regions, depend-
ing on their micro-architecture.
IOSs and Hemodynamics
It is well known that neuronal activity precedes hemodynamic
changes (Logothetis and Wandell, 2004). As early as 1890 was
the correlation made between blood flow changes and brain ac-
tivity (Roy and Sherrington, 1890), and changes in the level of
blood oxygenation are at the basis of the development of
BOLD fMRI in the 1990s (Ogawa et al., 1990). Vanzetta and Grin-
vald (1999) measured directly blood oxygenation levels and
Figure 6. Parenchymal IOSs Are Sensitive
to Extracellular Osmolarity
(A) Odor-evoked olfactory maps recorded in an
OMP-SpH mouse before (Ctrl; left) and 45 min
after water intoxication (H2O; right). LUT: 0.01
to 0.03.
(B) Time course of the activity of the glomerulus
marked in (A) before (Ctrl; black) and 45 min after
water intoxication (H2O; red).
(C) Amplitude of individual glomeruli signals after
injection (ordinate) as a function of the amplitude
before injection (abscissa) of saline (NaCl; black)
and water (H2O; red; n = 148 glomeruli from
four mice for H2O condition and n = 115 glomeruli
from four mice for NaCl condition; Mann-Whitney
U test; U(261) = 8276; p = 0.70).
(D) Averaged SpH amplitude across mice after
saline (NaCl; black) andwater (H2O; red; n= 4mice
from four mice for both water and saline injection;
unpaired t test; t(6) = 0.75; p = 0.48).
(E and F) Averaged breathing frequency (E) and
heart beat (F) across mice after saline (NaCl;
black) and water (H2O; red; n = 4 bulbs from four
mice for water and saline injection, respectively;
unpaired t test; t(6) = 0.87, p = 0.42 and t(6) =
2.9, p = 0.026 for resp. and heartbeat,
respectively).
(G) Odor-evoked IOS maps recorded before (Ctrl;
left) and 45 min after water intoxication (H2O;
right). LUT: 0.0025 to 0.0015.
(H) Time course of the activity of the glomerulus
marked in (G) before (Ctrl; black) and 45 min after
water intoxication (H2O; red).
(I) Amplitude of individual glomeruli signals after
injection (ordinate) as a function of the amplitude
before injection (abscissa) of saline (NaCl; black)
and water (H2O; red; n = 148 glomeruli from six
mice for H2O condition and n = 68 glomeruli
from five mice for NaCl condition; Mann-Whitney
U test; U(214) = 1,931; p = 3.6e13).
(J) Averaged IOS amplitude across mice after
saline (NaCl; black) and water (H2O; red; n = 6 and
5 bulbs from six and five mice for H2O and NaCl
condition, respectively; unpaired t test; t(9) =
2.8; p = 0.021).
(K and L) Averaged breathing frequency (K; n = 4 and 5 bulbs from four and five mice for H2O and NaCl condition, respectively; unpaired t test; t(7) = 0.8957;
p = 0.4002) and averaged heart beat (L; n = 2 and 3 bulbs from two and three mice for H2O and NaCl condition, respectively; unpaired t test; t(3) = 5.3467;
p = 0.0128) after saline (NaCl; black) and water injection (H2O; red).
The scale bars represent 250 mm in (A) and 100 mm in (G). Data are presented as mean ± SEM.showed an initial increase in Hb after sensory stimulation fol-
lowed by blood flow increase. Without the need for heavy equip-
ment or molecular reporter, intrinsic imaging in the cortex reveals
the same dynamics (Frostig et al., 1990; Grinvald et al., 1999),
and extensive modeling has been developed to understand
fine evolution of Hb, HbO, and HbT from intrinsic signals
(Mayhew et al., 1999). In our experiments, we do observe
changes in blood flow lagging glomerular IOSs by 1 s (Figures
1, 2, S1, and S2). One could argue that blood vessels distant
from an activated region could respond later or that larger blood
vessels have a response lagging the response in small capil-
laries. However, a similar time lag has been reported for capil-
laries located within activated glomeruli (Chaigneau et al.,
2007; Lecoq et al., 2009, 2011; Otsu et al., 2015; Petzold et al.,2008). We can thus safely rule out the contribution of blood
flow changes at least within the first second following stimulus
onset. We did not observe changes in rise time as a function of
wavelength; neither did we observe multiple components in
the rising phase of our intrinsic signals, ruling out a major contri-
bution of both blood oxygenation and flow changes throughout
the entire response-time course.
Altogether, our data strongly argue against a significant
impact of hemodynamics on parenchymal IOSs in the OB.
Although the contribution of hemodynamics to IOSs may vary
between brain areas, our data highlight the contribution of activ-
ity-dependent light-scattering signals, even at wavelengths usu-
ally considered reporting only hemodynamics. The interpretation
of IOSs collected at such wavelengths might then not beCell Reports 12, 313–325, July 14, 2015 ª2015 The Authors 321
straightforward and may explain some controversial IOS-based
results failing to link local neuronal activity and hemodynamics
(Handwerker and Bandettini, 2011; Kleinschmidt and Mu¨ller,
2010; Sirotin and Das, 2009).
Astrocytes and Neurovascular Coupling
Astrocytes are an indispensable element of neurovascular
coupling. Extensive work has been done on the topic, including
in the OB, revealing the crucial role of astrocytes in K+ clearance
(also called siphoning), glutamate reuptake, and vasodilation to
shuttle nutrients to and metabolites from active brain regions
(Attwell et al., 2010). A good part, if not all of these aspects rely
on intracellular Ca2+ signaling (Carmignoto andGo´mez-Gonzalo,
2010). In our experiments, neither K+ siphoning (blocked by
Ba2+) nor glutamate reuptake (blocked by DHK) affected glomer-
ular intrinsic signals, and the block of metabotropic glutamate
receptors almost completely abolished odor-induced Ca2+ tran-
sients in astrocytes (Figures 3 and 4). One published work
concluded from the disruption of odor-evoked IOSs by TBOA
that these signals were arising from astrocyte swelling (Gurden
et al., 2006). However, the use of this drug at the same concen-
tration proves to block almost completely the release of
glutamate by OSNs (Figures 4A–4C), rendering this experiment
inconclusive. A further confirmation of the absence of implication
of glutamate transporters in IOS generation came from the unex-
pected reversal of the TBOA effect on OSN activity by the
addition of APV and NBQX (ionotropic glutamate receptor antag-
onists). Indeed, in the presence of TBOA, APV, and NBQX, con-
ditions in which glutamate transporters are blocked (as well as
ionotropic glutamate receptors), both SpH signals and IOSs
are clearly visible (Figure 4C). A proper understanding of this sur-
prising finding would require more investigation, but it reveals a
misinterpretation of the data presented in Gurden et al. (2006).
Morphological Correlates of Neuronal Activity and
Relevance for Functional Brain Imaging
A number of studies have described shrinkage of the extracel-
lular space induced by neuronal activity (Jarvis et al., 1999;
Sykova´ et al., 2003). However, none of these experiments were
performed in vivo, and the conclusions diverge on the cellular
basis of this phenomenon. In vitro, axons have been shown to
swell (Cohen et al., 1968; Fields and Ni, 2010), as well as neuron
cell bodies and astrocytes (Sykova´ et al., 2003). These mor-
phological changes are a consequence of the massive ion
exchanges across neuronal and astrocytic membranes. The cor-
relation between extracellular space shrinkage and IOSs has
been studied in vitro and revealed that activity-dependent light
scattering changes can indeed be optically recorded (Jarvis
et al., 1999; Sykova´ et al., 2003). However, the precise contribu-
tion of extracellular space shrinkage, fine morphological
changes, protein packing, or cleavage is a matter of debate (Jar-
vis et al., 1999; Sykova´ et al., 2003). In the present study, we did
not attempt to measure morphological changes of neuronal and
astrocytic processes directly. However, we manipulated the
extracellular space and reproduced a pathological condition
(edema) known to alter water diffusion (Manley et al., 2000;
Schaefer et al., 2000). In this experiment, we saw a near extinc-
tion of IOSs with intact neurotransmitter release (Figure 6). Sol-322 Cell Reports 12, 313–325, July 14, 2015 ª2015 The Authorsutes and water movements across membranes are associated
with cell swelling. It is thus likely that the observedmorphological
changes in OSNs generating odor-evoked IOSs are coming from
the activity-induced swelling of their axons.
The change in optical properties measured with IOS imaging is
an interesting correlate of neuronal activity and can be used in
humans. Activity-induced changes in water diffusion have
been measured with MRI in the human visual cortex (Le Bihan
et al., 2006), and their correlation with neuronal activity was
confirmed in the rat somatosensory cortex (Tsurugizawa et al.,
2013). We hypothesize here that the signals measured with diffu-
sion fMRI are of similar origin than the IOSs measured in our ex-
periments. These two techniques can be used in humans and
present the advantage to have faster kinetics than BOLD signals
and to be less sensitive to anesthetics and drugs affecting the
circulatory system. Additionally, signals from diffusion fMRI
and IOSs are more spatially restricted to the activated neuronal
networks than signals from BOLD fMRI and are therefore more
accurate to map neuronal activity.
EXPERIMENTAL PROCEDURES
Animals
All experiments were performed on 12- to 20-week-old male and female mice.
We used C57BL/6J (Charles River France; for IOS imaging) and hemizygous
Omptm2(SpH)Mom (Bozza et al., 2004; OMP-SpH; Jackson Laboratory; JAX
004946), and for calcium imaging experiments, we crossed mice condition-
ally expressing the calcium indicator GCaMP3 (Gt(ROSA)26Sortm38(CAG-
GCaMP3)Hze/J; Zariwala et al., 2012; JAX 014538) with different cell-type-
specific Cre-expressing lines. For OSNs, astrocytes, and M/T cells, we used
Omptm4(cre)Mom (Li et al., 2004; OMP-Cre; JAX 006668; always kept hemizy-
gous), B6.Cg-Tg505Fmv/J (GFAP-creERT; JAX 012849), and Tg(Pcdh21-
creERT)CYoko (Yonekura and Yokoi, 2008; kind gift of Dr. Mineto Yokoi)
mice, respectively. The creERT recombinase was activated by three intraper-
itoneal injections (one injection per day for 3 consecutive days, around
postnatal day 21) of tamoxifen (100 ml; from a stock solution of 10 mg/ml
tamoxifen in Corn Oil; Sigma-Aldrich). Finally, floxed Nav1.7 (Nassar et al.,
2004) were crossedwith OMP-Cre (see above) mice to prevent Nav1.7 expres-
sion in OSNs (mice were kindly provided by Drs. Frank Zufall and Trese
Leinders-Zufall).
All experiments were in accordance with the Swiss Animal Protection Ordi-
nance andwere approved by the University of Geneva andGeneva state ethics
committees.
Recordings in Awake Mice
During the 3 days prior to the recordings, mice were habituated to be head
restrained on the recording setup for 23 30 min per day (Gschwend et al.,
2012). The day of the recording, mice were briefly anesthetized with isoflurane
(3% to 4% induction; 1% to 2% maintenance). The bone was thinned with a
scalpel blade to achieve good optical access. Animals were left to fully recover
for at least 30 min before starting imaging sessions. See also Supplemental
Experimental Procedures.
Recordings in Anesthetized Mice
Animals were deeply anesthetized, and a circular craniotomy (using a 2-mm
biopsy punch; Harris UNI-CORE) was made over the OB, leaving the dura
intact. The craniotomy was filled with ACSF and covered with a glass coverslip
(5 mm of diameter). See also Supplemental Experimental Procedures.
All the drugs used, except for Cd2+ and Ba2+ (purchased fromSigma Aldrich)
were purchased from Tocris Bioscience. Drugs were dissolved in ACSF
containing in mM 125 NaCl, 10 glucose, 10 HEPES, 5 KCl, 2 CaCl2, and
2 MgCl2. Ten microliters of ACSF with or without drugs were topically applied
to the surface of one OB. After removing the cover glass, the dura mater was
dried by gently puffing air. Drugs were applied on the dried dura, and a cover
glass was placed back on the craniotomy. This procedure allows the dura
membrane to be more permeable to pharmacological agents.
For water intoxication experiments, a volume of 20% of mouse body
weight of distilled water (dH2O) or sterile isotonic solution (308 mosm/l,
0.9% NaCl; Sintetica-Bioren SA) was injected i.p. (Manley et al., 2000). The
pH (7.3) and temperature (37C) of the solution were checked before each
injection.
Imaging Experiments
To perform intrinsic signal imaging, the OB was illuminated with incident light
using a stable 100-W halogen lamp with light guides (Bathellier et al., 2008).
The wavelength of incident light was varied depending on experimental needs
using the following interference filters: 546 (BP 30 nm); 605 (BP 30 nm); 700 (BP
30 nm); and 810 nm (BP 30 nm). Images were acquired at 5 Hz for 10 s using
the Imager 3001F system (Optical Imaging) or at 14 Hz using theMicamUltima
system (Brainvision) mounted both on a custom-built macroscope (Patterson
et al., 2013; Navitar 17 mm or 25 mm, bottom lenses; Nikon 135 mm, upper
lens; total magnification 7.93 or 5.43). See also Supplemental Experimental
Procedures.
Odor Delivery
All monomolecular odorants used in the experiments (amyl acetate, ethyl buty-
rate, isoamyl acetate, carvone-, 3-hexanone, acetophenone, and methyl
benzoate) were from Sigma-Aldrich. See also Supplemental Experimental
Procedures.
Data Analysis and Statistical Analysis
All analyses were performed with customMatlab (MathWorks) scripts and Sta-
tistica. See also Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.06.016.
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